Responses
Clinical and epidemiological research
Extended report
Decrease in immunoglobulin free light chains in patients with rheumatoid arthritis upon rituximab (anti-CD20) treatment correlates with decrease in disease activity
Compose a Response to This Article
Other responses
No responses have been published for this article.